ASB2α, an E3 Ubiquitin Ligase Specificity Subunit, Regulates Cell Spreading and Triggers Proteasomal Degradation of Filamins by Targeting the Filamin Calponin Homology 1 Domain

被引:14
|
作者
Razinia, Ziba [1 ]
Baldassarre, Massimiliano [2 ]
Cantelli, Gaia [2 ]
Calderwood, David A. [1 ,2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
ACTIN-BINDING DOMAIN; LEUKEMIA-CELLS; ALPHA-ACTININ; MUTATIONS; DIFFERENTIATION; MIGRATION; PROTEIN; DIMERIZATION; MYOPATHY; HEMATOPOIESIS;
D O I
10.1074/jbc.M113.496604
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Filamins are actin-binding and cross-linking proteins that organize the actin cytoskeleton and anchor transmembrane proteins to the cytoskeleton and scaffold signaling pathways. During hematopoietic cell differentiation, transient expression of ASB2 alpha, the specificity subunit of an E3-ubiquitin ligase complex, triggers acute proteasomal degradation of filamins. This led to the proposal that ASB2 alpha regulates hematopoietic cell differentiation by modulating cell adhesion, spreading, and actin remodeling through targeted degradation of filamins. Here, we show that the calponin homology domain 1 (CH1), within the filamin A (FLNa) actin-binding domain, is the minimal fragment sufficient for ASB2 alpha-mediated degradation. Combining an in-depth flow cytometry analysis with mutagenesis of lysine residues within CH1, we find that arginine substitution at each of a cluster of three lysines (Lys-42, Lys-43, and Lys-135) renders FLNa resistant to ASB2 alpha-mediated degradation without altering ASB2 alpha binding. These lysines lie within previously predicted actin-binding sites, and the ASB2 alpha-resistant filamin mutant is defective in targeting to F-actin-rich structures in cells. However, by swapping CH1 with that of alpha-actinin1, which is resistant to ASB2 alpha-mediated degradation, we generated an ASB2 alpha-resistant chimeric FLNa with normal subcellular localization. Notably, this chimera fully rescues the impaired cell spreading induced by ASB2 alpha expression. Our data therefore reveal ubiquitin acceptor sites in FLNa and establish that ASB2 alpha-mediated effects on cell spreading are due to loss of filamins.
引用
收藏
页码:32093 / 32105
页数:13
相关论文
共 50 条
  • [1] The E3 ubiquitin ligase specificity subunit ASB2α targets filamins for proteasomal degradation by interacting with the filamin actin-binding domain
    Razinia, Ziba
    Baldassarre, Massimiliano
    Bouaouina, Mohamed
    Lamsoul, Isabelle
    Lutz, Pierre G.
    Calderwood, David A.
    JOURNAL OF CELL SCIENCE, 2011, 124 (15) : 2631 - 2641
  • [2] The E3 ubiquitin ligase specificity subunit ASB2β is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation
    N F Bello
    I Lamsoul
    M L Heuzé
    A Métais
    G Moreaux
    D A Calderwood
    D Duprez
    C Moog-Lutz
    P G Lutz
    Cell Death & Differentiation, 2009, 16 : 921 - 932
  • [3] The E3 ubiquitin ligase specificity subunit ASB2β is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation
    Bello, N. F.
    Lamsoul, I.
    Heuze, M. L.
    Metais, A.
    Moreaux, G.
    Calderwood, D. A.
    Duprez, D.
    Moog-Lutz, C.
    Lutz, P. G.
    CELL DEATH AND DIFFERENTIATION, 2009, 16 (06): : 921 - 932
  • [4] The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation
    Thottakara, Tilo
    Friedrich, Felix W.
    Reischmann, Silke
    Braumann, Simon
    Schlossarek, Saskia
    Kraemer, Elisabeth
    Juhr, Denise
    Schlueter, Hartmut
    van der Velden, Jolanda
    Muench, Julia
    Patten, Monica
    Eschenhagen, Thomas
    Moog-Lutz, Christel
    Carrier, Lucie
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2015, 87 : 214 - 224
  • [5] Filamins but Not Janus Kinases Are Substrates of the ASB2α Cullin-Ring E3 Ubiquitin Ligase in Hematopoietic Cells
    Lamsoul, Isabelle
    Erard, Monique
    van der Ven, Peter F. M.
    Lutz, Pierre G.
    PLOS ONE, 2012, 7 (08):
  • [6] The E3 1Lgase Asb2 Regulates Cardiac Development Through Targeting Smad9 for Proteasomal Degradation
    Min, Kyung-Duk
    Asakura, Masanori
    Ito, Shin
    Shirai, Manabu
    Yamazaki, Satoru
    Asanuma, Hiroshi
    Mochizuki, Naoki
    Kitakaze, Masafurni
    CIRCULATION, 2013, 128 (22)
  • [7] The E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation
    Cheng, Mingyang
    Lu, Yiyuan
    Wang, Jiarui
    Wang, Haixu
    Sun, Yu
    Zhao, Wenhui
    Wang, Junhong
    Shi, Chunwei
    Luo, Jiawei
    Gao, Ming
    Yu, Tianxin
    Wang, Jianzhong
    Guan, Jiayao
    Wang, Nan
    Yang, Wentao
    Jiang, Yanlong
    Huang, Haibin
    Yang, Guilian
    Cao, Xin
    Yang, Dongqin
    Wang, Chunfeng
    Zeng, Yan
    CELL DEATH AND DIFFERENTIATION, 2024, : 1746 - 1760
  • [8] The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer
    Spinner, Camille A.
    Lamsoul, Isabelle
    Metais, Arnaud
    Febrissy, Chanaelle
    Moog-Lutz, Christel
    Lutz, Pierre G.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (08) : 1332 - 1344
  • [9] E3 ubiquitin ligase ASB8 promotes selinexor-induced proteasomal degradation of XPO1
    Kwanten, Bert
    Deconick, Tine
    Walker, Christopher
    Wang, Feng
    Landesman, Yosef
    Daelemans, Dirk
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 160
  • [10] Temporal Ubiquitin-Proteasomal Degradation of Smad9 Mediated by its Specific E3 Ligase Asb2 is Required for Cardiac Development through the Regulation of Tbx2 Expression
    Min, Kyung-Duk
    Asakura, Masanori
    Ito, Shin
    Imazu, Miki
    Shindo, Kazuhiro
    Kitakaze, Masafumi
    CIRCULATION RESEARCH, 2014, 115